INS and early-onset autosomal dominant Alzheimer disease: These results suggest that a low cerebral glucose metabolic rate is linked to higher cerebral glucose concentrations and reduced brain insulin sensitivity, contributing to Alzheimer’s disease pathologies in humans [59].